Dr. Matthew G Davis, MD
Claim this profileGSK Investigational Site
Studies Respiratory Syncytial Virus
Studies Chikungunya Fever
18 reported clinical trials
27 drugs studied
Affiliated Hospitals
Clinical Trials Matthew G Davis, MD is currently running
PXVX0317 Booster
for Chikungunya
The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunogenicity of CHIKV VLP vaccine in adult and adolescent participants and to evaluate CHIKV VLP booster vaccine induced serum neutralizing antibody (SNA) response at 3, 4, or 5 years post-initial CHIKV VLP vaccination.
Recruiting1 award Phase 3
Vaccine
for Respiratory Syncytial Virus
The aim of this study is to demonstrate the immune response and to evaluate safety of the RSVPreF3 OA investigational vaccine in non-immunocompromised adults 18-49 years of age (YOA), who are at increased risk (AIR) for respiratory syncytial virus (RSV) disease, compared to older adults (OA) (\>=) 60 YOA and above
Recruiting2 awards Phase 33 criteria
More about Matthew G Davis, MD
Clinical Trial Related1 year of experience running clinical trials · Led 18 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Matthew G Davis, MD has experience with
- PXVX0317
- RSVPreF3 OA Vaccine
- RSVPreF3 OA Investigational Vaccine
- Placebo
- Bivalent GII.4/GI.1 Vaccine
- 24 Valent Pneumococcal Conjugate Vaccine
Breakdown of trials Matthew G Davis, MD has run
Respiratory Syncytial Virus
Chikungunya Fever
Chikungunya
Pneumococcal Vaccines
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew G Davis, MD specialize in?
Matthew G Davis, MD focuses on Respiratory Syncytial Virus and Chikungunya Fever. In particular, much of their work with Respiratory Syncytial Virus has involved treating patients, or patients who are undergoing treatment.
Is Matthew G Davis, MD currently recruiting for clinical trials?
Yes, Matthew G Davis, MD is currently recruiting for 5 clinical trials in Rochester New York. If you're interested in participating, you should apply.
Are there any treatments that Matthew G Davis, MD has studied deeply?
Yes, Matthew G Davis, MD has studied treatments such as PXVX0317, RSVPreF3 OA vaccine, RSVPreF3 OA investigational vaccine.
What is the best way to schedule an appointment with Matthew G Davis, MD?
Apply for one of the trials that Matthew G Davis, MD is conducting.
What is the office address of Matthew G Davis, MD?
The office of Matthew G Davis, MD is located at: GSK Investigational Site, Rochester, New York 14609 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.